Clinical Trial Update: Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

View source ↗

Summary

Clinical trial update indicating a completed study of sub-cutaneous infliximab for inflammatory rheumatic diseases, including rheumatoid arthritis, spondyloarth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis
• Rheumatoid Arthritis
• Spondyloarthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Rheumatoid Arthritis, Spondyloarthritis | Status: COMPLETED